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Abstract
BrisSynBio is the Bristol-based Biotechnology and Biological Sciences Research Council (BBSRC)/Engineering
and Physical Sciences Research Council (EPSRC)-funded Synthetic Biology Research Centre. It is one of six
such Centres in the U.K. BrisSynBio’s emphasis is on rational and predictive bimolecular modelling, design
and engineering in the context of synthetic biology. It trains the next generation of synthetic biologists in
these approaches, to facilitate translation of fundamental synthetic biology research to industry and the
clinic, and to do this within an innovative and responsible research framework.
BrisSynBio is supported by £13.6 million from Bi-
otechnology and Biological Sciences Research Council
(BBSRC)/Engineering andPhysical SciencesResearchCoun-
cil (EPSRC), which includes a £3.3 million investment in new
state-of-the-art equipment and computing, and significant
additional University of Bristol support. BrisSynBio is led by
the University of Bristol in partnership with the University
of the West of England. It is a multidisciplinary Centre
distributed across four Faculties, with an administrative
hub in University of Bristol’s new £56 million Life
Sciences Building (Figure 1). BrisSynBio partners include:
SynBiCITE, the Imperial College-led synthetic biology
industrial translation engine; Oxford and Warwick to
deliver the EPSRC/BBSRC-funded Centre for Doctoral
Training in Synthetic Biology; and the EU-wide SYNEN-
ERGENE project exploring public engagement in synthetic
biology.
BrisSynBio’s Director, Professor Dek Woolfson, is one of
the U.K.’s leading advocates for advancing and broadening
synthetic biology approaches to include biomolecular
design and engineering [1]. He has published influential
papers in these areas [2–4], well-cited reviews [1] and
commentaries [5]. Woolfson’s research is at the interface
between the physical and biological sciences, and specifically
in computational and experimental aspects of protein design
and its application to synthetic biology. He is supported
by the Centre’s Co-Director, Dr Paul Race, whose work
focuses on the exploitation and manipulation of enzyme
complexes, pathways and networks, en route to developing
new tools, technologies and products for red, green and
white biotechnology. Race has co-authored papers in leading
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international journals [6–8] and has a strong track record of
industrial engagement.
BrisSynBio’s scientific focus is on the rational design and
engineering of nucleic acids, lipids, peptides and proteins
as structural, enzymatic and regulatory components in new
biological and bio-inspired systems. BrisSynBio is organized
into three research Strands:
Strand 1 – Enzyme Cascades and Cell Factories:
This strand focuses on the isolation, characterization and
scalable production of ‘new-to-science’ natural product-
based therapeutics and agrochemicals. A major emphasis is
polyketides, the most structurally and functionally diverse
family of bioactive natural products known. These molecules
represent challenging, frequently intractable targets for
synthetic organic chemistry, and as such biosynthesis
offers the only generally applicable route to efficient
production. Exemplar projects include: engineering Trans-
acyltransferase (AT) polyketide synthase (PKS) antibiotic
gene clusters todeliver bioactive compounds, ledbyWillis [9];
scalable biosynthetic platforms for polyketide production in
Escherichia coli, led by Race [6–8]; and molecular membrane
engineering for nanoreactor bionetworks, led by Collinson
[10].
Strand 2 – Self-assembled Systems and Minimal Cells:
This strand explores using and combining stripped-down
biological components andmachinery tobuild virus- and cell-
likemicro-compartments. It involves the systematic inclusion
and networking of engineered biomolecular and cellular
components, and gene circuitry to establish biomimetic
operations and modules. Achieving this vision depends
critically on the construction and design of self-assembled
systems, novel representations of synthetic cellularity
and re-engineering of minimal cells. Exemplar projects
include: developing hybrid peptide-virus nanoparticles for
immunology and cell delivery, led by Woolfson [1–4]; design
and construction of solar energy transducing oxidoreductase
cascades within metabolic protocells, led by Mann [11];
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Figure 1 BrisSynBio illustration by Andy Council, 2014
This image was created by Andy Council in collaboration with BrisSynBio
in 2014. Andy is a Bristol-based artist and illustrator. His style is instantly
recognizable in and around Bristol: he ‘creates composite beasts made
up of architectural landmarks and other recognizable elements’; and
some of his work is visible in the streets of Bristol and on display at the
M Shed in the city. The illustration invites the viewer to take a peek inside
a cell through a window cut into the cell wall, with the latter created
from illustrations of the buildings at the University of Bristol most closely
associated with BrisSynBio.
and engineering red blood cells as drug delivery agents and
bioreactors, led by Toye [12].
Strand 3 – Programming Complexity in Natural
Systems: Strand 3 integrates modelling, cell biology and
imaging to address the predictable reprogramming and
control of single cells, cell populations and cells in
multicellular organisms. Applications are envisaged for
whole-cell biosensors for the detection, analysis and
remediation of aromatic pollutants; the use of engineered cells
to control cell populations; and the development of wheat
strains with the potential to revolutionize wheat breeding
for agriculturally important traits. Exemplar projects include:
design and implementation of orthogonal components for
transcriptional logic gates, led by Savery [13]; harnessing
synthetic oscillators, led by di Bernardo [14]; and a
synthetic pathway for recombination in wheat, led by
Edwards [15]. The first BrisSynBio Fellow in Synthetic
Biology, Gorochowski, has joined this Strand working
on tools for the rational design of synthetic gene circuits
[16].
The Strands are supported by three cross-cutting Themes
in: Design and Characterization of Biomolecular Compon-
ents; Engineering and Modelling across Scales; and Public
Engagement and Responsible Research and Innovation. For
the second of these, three computational scientists are
employed to cover theoretical aspects and computational
modelling and simulation. Sophisticated models can help
predict the outcome of experiments, and hence inform which
experiments are most likely to provide useful outcomes.
Additionally, they offer powerful methods for interpreting
experimental results. BrisSynBio has built upon existing close
relationships between modelling and experimental groups
by providing an interface across the scales of modelling
that are addressed by different research groups at Bristol so
that experimental researchers can readily collaborate with
the appropriate group for the scale of problem they are
addressing: atomistic molecular modelling and simulation,
led by Sessions and co-workers [2,3,17]; modelling catalytic
mechanisms, led by Mulholland [18]; and coarse-grained
modelling, led by Liverpool [19].
In Theme 3, Kent [20] leads the project exploring
fundamental problems, ethics and responsible innovation in
the design and engineering of synthetic-biological systems.
A philosopher works alongside BrisSynBio researchers,
examining what ‘responsible innovation’ and ‘ethical science’
mean in practice, as well as fundamental ethical and
philosophical questions raised by BrisSynBio’s research and
synthetic biology activities more broadly. As part of this
aspect of BrisSynBio, the Centre and its researchers are
proactively involved in a range of public engagement, from
traditional science cafes and visits to local schools, to
innovations such as Question Time-style panel discussions
and supporting a show at the 2015 Edinburgh Fringe [21].
All of these research activities are underpinned by major
new facilities supported through the Centre grant for: high-
throughput molecular biology; NMR spectroscopy and pep-
tide synthesis; high-performance computing; microfluidics;
FACS; and advanced microscopy and imaging. And to help
pave the way to applications, BrisSynBio’s current industrial
partners include Bruker, GSK, Syngenta and UCB, through
which BrisSynBio aims to realize translational outcomes
in the areas of fine and specialty chemicals, medicines and
healthcare, and wheat breading.
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